VERONICA DORAN: Open Payments
NPI 1518450345 · ARLINGTON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,421 in 73 payments from 16 companies in 2025. Trend: 2023 $1,104 · 2024 $911 · 2025 $1,421
Food & beverage: $1,421
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 12 | $263 |
| Corium, LLC | 8 | $159 |
| Lundbeck LLC | 8 | $144 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $142 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $128 |
| Vanda Pharmaceuticals Inc. | 4 | $117 |
| Axsome Therapeutics, Inc. | 8 | $100 |
| E.R. Squibb & Sons, L.L.C. | 2 | $57 |
| ABBVIE INC. | 3 | $54 |
| Teva Pharmaceuticals USA, Inc. | 2 | $49 |
Products named: REXULTI, Azstarys, TRINTELLIX, CAPLYTA, HETLIOZ, Auvelity, COBENFY, VRAYLAR.
Industry payments across VA — which companies pay providers there.
